AZOPT 10 mg/ml EYE DROPS IN SUSPENSION
How to use AZOPT 10 mg/ml EYE DROPS IN SUSPENSION
Translated with AI
This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.
Show originalContents of the leaflet
Introduction
Package Leaflet: Information for the User
AZOPT 10 mg/ml eye drops, suspension
brinzolamide
Read the package leaflet carefully before you start using this medicine because it contains important information for you.,
- Keep this package leaflet, you may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
- If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.
Contents of the package leaflet
- What is AZOPT and what is it used for
- What you need to know before you use AZOPT
- How to use AZOPT
- Possible side effects
- Storing AZOPT
- Package contents and further information
1. What is AZOPT and what is it used for
AZOPT contains brinzolamide which belongs to a group of medicines called carbonic anhydrase inhibitors and reduces the pressure inside the eye.
AZOPT eye drops are used to treat high pressure in the eyes. This pressure can lead to an illness called glaucoma.
If the pressure in the eye is too high, it can damage your sight.
2. What you need to know before you use AZOPT
Do not use AZOPT
- if you have severe kidney problems.
- if you are allergic to brinzolamide or any of the other ingredients of this medicine (listed in section 6).
- if you are allergic to a group of medicines called sulfonamides. Examples: medicines used to treat diabetes and infections and also diuretics (water pills). AZOPT could cause you the same allergy.
- if you have too much acid in the blood (a disease called hyperchloremic acidosis).
If you are not sure, consult your doctor.
Warnings and precautions
Consult your doctor or pharmacist before you start using AZOPT:
- if you have kidney or liver problems.
- if you have dry eye or cornea problems.
- if you are using other medicines that contain sulfonamides.
- if you have a specific type of glaucoma where the pressure in the eye increases due to deposits that block the drainage of fluid in the eye (pseudoexfoliative glaucoma or pigmentary glaucoma) or a specific type of glaucoma where the pressure in the eye increases (sometimes rapidly) due to a bulge towards the front of the eye that blocks the drainage of fluid (narrow-angle glaucoma).
- if you have ever developed a severe skin rash or skin peeling, blisters and/or sores in the mouth after using AZOPT or other related medicines.
Be careful with AZOPT:
Severe skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported in association with brinzolamide treatment. Stop using AZOPT and seek immediate medical attention if you notice any of the symptoms related to these severe skin reactions described in section 4.
Children and adolescents
AZOPT should not be used in infants, children, and adolescents under 18 years, unless your doctor recommends it.
Other medicines and AZOPT
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines, including those obtained without a prescription.
Consult your doctor if you are using another carbonic anhydrase inhibitor (acetazolamide or dorzolamide, see section 1 What is AZOPT and what is it used for).
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
Women who may become pregnant are advised to use effective contraceptive methods during treatment with AZOPT. The use of AZOPT is not recommended during pregnancy or breastfeeding. Do not use AZOPT unless clearly indicated by your doctor.
Consult your doctor or pharmacist before using any medicine.
Driving and using machines
Do not drive or use machines until your vision is clear. Immediately after applying AZOPT, you may notice that your vision becomes blurred.
AZOPT may worsen your ability to perform tasks that require mental alertness and/or physical coordination. If you notice these effects, be careful when driving or using machines.
AZOPT contains benzalkonium chloride
This medicine contains 3.35 µg of benzalkonium chloride per drop (= 1 dose), equivalent to 0.01% or 0.1 mg/ml.
AZOPT contains a preservative (benzalkonium chloride) that can be absorbed by soft contact lenses and may alter the color of the contact lenses. Remove contact lenses before using this medicine and wait 15 minutes before putting them back. Benzalkonium chloride may cause eye irritation, especially if you have dry eye or other corneal diseases (the transparent layer of the front of the eye). Consult your doctor if you feel any unusual sensation, itching, or pain in the eye after using this medicine.
3. How to use AZOPT
Follow the instructions for administration of this medicine exactly as indicated by your doctor or pharmacist. If you are not sure, consult your doctor or pharmacist again.
Use AZOPT only in your eye(s). Do not swallow or inject.
The recommended dose is1 drop in the affected eye(s) twice a day - in the morning and at night.
This is the dosage you should follow unless your doctor has indicated otherwise. You should only apply AZOPT to both eyes if your doctor has recommended it. Continue the treatment for the entire period of time indicated by your doctor.
How to use
1 2 3
- Take the AZOPT bottle and stand in front of a mirror
- Wash your hands
- Shake the bottle and unscrew the cap. After removing the cap, you must remove the security seal ring if it is loose before using this medicine
- Hold the bottle, upside down, between your thumb and index finger
- Tilt your head back. Gently pull the lower eyelid down to form a pocket, where the drop should fall (figure 1)
- Bring the tip of the bottle close to the eye. You can use a mirror to help you
- Do not touch the eye, eyelid, or surrounding areas with the dropper, as the drops could become contaminated
- Gently press the base of the bottle to release one drop of AZOPT at a time
- Do not squeeze the bottle: it is designed to release one drop with a gentle pressure on the base (figure 2)
- After using AZOPT, press the edge of the eye, next to the nose (figure 3) for at least 1 minute. This helps prevent AZOPT from passing into the rest of the body
- If you are applying drops to both eyes, repeat all the previous steps with the other eye
- Screw the cap back on the bottle immediately after use
- Finish the bottle you are using before opening the next one
If a drop falls outside the eye, try again.
If you are using another eye drop, wait at least 5 minutes between applying AZOPT and the other drops. Ophthalmic ointments should be applied last.
If you use more AZOPT than you should
If you have applied too much, you can remove it by rinsing your eyes with warm water. Do not apply more drops until it is time for your next dose.
If you forget to use AZOPT
Apply a drop as soon as you remember and then continue with your usual treatment schedule. Do not apply a double dose to make up for forgotten doses.
If you stop using AZOPT
If you stop using AZOPT without consulting your doctor, the pressure in your eye will not be controlled, which could lead to loss of vision.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following side effects have been observed with AZOPT.
Stop using AZOPT and seek immediate medical attention if you notice any of the following symptoms:
- red patches, target-like or circular, on the trunk, often with central blisters, skin peeling, ulcers in the mouth, throat, nose, genitals, and eyes. These severe skin rashes can be preceded by fever and flu-like symptoms (Stevens-Johnson syndrome, toxic epidermal necrolysis).
Common(may affect up to 1 in 10 people)
- Eye effects:blurred vision, eye irritation, eye pain, eye discharge, eye itching, dry eye, abnormal sensation in the eye, eye redness.
- Other side effects: bad taste.
Uncommon(may affect up to 1 in 100 people)
- Eye effects:sensitivity to light, conjunctivitis, eye swelling, itching, redness or swelling of the eyelid, deposits in the eye, glare, burning sensation, lump on the surface of the eye, increased pigmentation of the eye, tired eyes, crusts on the eyelid, increased tear production.
- Other side effects:reduced or decreased heart function, strong or irregular heartbeats, decreased heart rate, difficulty breathing, shortness of breath, cough, decreased red blood cell count, increased chloride levels in the blood, dizziness, memory problems, depression, nervousness, decreased emotional interest, nightmares, weakness, fatigue, feeling abnormal, pain, movement problems, decreased sexual behavior, sexual problems in men, cold symptoms, chest congestion, nasal passage infection, throat irritation, sore throat, abnormal or decreased sensation in the mouth, esophageal mucosa inflammation, abdominal pain, nausea, vomiting, stomach pain, frequent bowel movements, diarrhea, gas, digestive disorders, kidney pain, muscle pain, muscle spasms, back pain, nosebleeds, nasal discharge (runny nose), stuffy nose, sneezing, rash, abnormal sensation on the skin, itching, smooth or red skin rash, skin tightness, headache, dry mouth, particles in the eye.
Rare(may affect up to 1 in 1,000 people)
- Eye effects:corneal swelling, double or decreased vision, abnormal vision, flashes of light in the field of vision, decreased eye sensitivity, swelling around the eye, increased pressure in the eye, optic nerve damage.
- Other side effects:memory loss, drowsiness, chest pain, upper respiratory tract congestion, sinus congestion, nasal congestion, nasal dryness, ringing in the ears, hair loss, generalized itching, feeling restless, irritability, irregular heartbeat, general weakness, difficulty sleeping, wheezing, skin rash with itching.
Frequency not known(cannot be estimated from the available data)
- Eye effects:eyelid abnormality, vision changes, corneal changes, eye allergy, decreased eyelash growth or number, eyelid redness.
- Other side effects:increased allergy symptoms, decreased sensation, tremor, decreased or lost taste, decreased blood pressure, increased blood pressure, increased heart rate, joint pain, asthma, pain in limbs, itching, skin inflammation or redness, abnormal liver blood test results, swelling of limbs, frequent need to urinate, decreased appetite, general malaise, red patches, target-like or circular, on the trunk, often with central blisters, skin peeling, ulcers in the mouth, throat, nose, genitals, and eyes that may be preceded by fever and flu-like symptoms. These severe skin rashes can be potentially life-threatening (Stevens-Johnson syndrome, toxic epidermal necrolysis).
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the national reporting system listed in Annex V. By reporting side effects, you can help provide more information on the safety of this medicine.
5. Storing AZOPT
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the bottle and carton after “EXP”. The expiry date is the last day of the month shown.
This medicine does not require any special storage conditions.
To avoid infections, you must discard each bottle four weeks after you first open it.Write the date you open each bottle on the space below and on the label of the bottle and carton. For the pack containing only one bottle, write only one date.
Opening date (1):
Opening date (2):
Opening date (3):
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
6. Container contents and additional information
AZOPT composition
- The active ingredient is brinzolamide. Each milliliter contains 10 mg of brinzolamide.
- The other components are benzalkonium chloride, carbomer 974P, disodium edetate, mannitol (E421), purified water, sodium chloride, and tyloxapol. Very small amounts of hydrochloric acid or sodium hydroxide are added to maintain normal acidity levels (pH levels).
Product appearance and container contents
AZOPT is a milky-looking liquid (a suspension) that comes in a box containing a 5-ml or 10-ml plastic bottle with a screw cap, or in a box containing three 5-ml plastic bottles with screw caps. Only certain package sizes may be marketed.
Marketing authorization holder
Novartis Europharm Limited
Vista Building
Elm Park, Merrion Road
Dublin 4
Ireland
Manufacturer responsible
Novartis Pharma GmbH
Roonstraße 25
D-90429 Nuremberg
Germany
Novartis Manufacturing NV
Rijksweg 14
2870 Puurs-Sint-Amands
Belgium
Novartis Farmacéutica, S.A.
Gran Via de les Corts Catalanes, 764
08013 Barcelona
Spain
Siegfried El Masnou, S.A.
Camil Fabra 58
El Masnou
08320 Barcelona
Spain
Novartis Pharma GmbH
Sophie-Germain-Strasse 10
90443 Nürnberg
Germany
You can request more information about this medication by contacting the local representative of the marketing authorization holder:
België/Belgique/Belgien Novartis Pharma N.V. Tél/Tel: +32 2 246 16 11 | Lietuva Novartis Pharma Services Inc. Tel: +370 5 269 16 50 |
Novartis Pharma Services Inc. Тел: +359 2 489 98 28 | Luxembourg/Luxemburg Novartis Pharma N.V. Tél/Tel: +32 2 246 16 11 |
Ceská republika Novartis s.r.o. Tel: +420 225 775 111 | Magyarország Novartis Hungária Kft. Tel.: +36 1 457 65 00 |
Danmark Novartis Healthcare A/S Tlf: +45 39 16 84 00 | Malta Novartis Pharma Services Inc. Tel: +356 2122 2872 |
Deutschland Novartis Pharma GmbH Tel: +49 911 273 0 | Nederland Novartis Pharma B.V. Tel: +31 26 37 82 111 |
Eesti Novartis Pharma Services Inc. Tel: +372 66 30 810 | Norge Novartis Norge AS Tlf: +47 23 05 20 00 |
Ελλάδα Novartis (Hellas) A.E.B.E. Τηλ: +30 210 281 17 12 | Österreich Novartis Pharma GmbH Tel: +43 1 86 6570 |
España Novartis Farmacéutica, S.A. Tel: +34 93 306 42 00 | Polska Novartis Poland Sp. z o.o. Tel.: +48 22 375 4888 |
France Novartis Pharma S.A.S. Tél: +33 1 55 47 66 00 | Portugal Novartis Farma - Produtos Farmacêuticos, S.A. Tel: +351 21 000 8600 |
Hrvatska Novartis Hrvatska d.o.o. Tel. +385 1 6274 220 | România Novartis Pharma Services Romania SRL Tel: +40 21 31299 01 |
Ireland Novartis Ireland Limited Tel: +353 1 260 12 55 | Slovenija Novartis Pharma Services Inc. Tel: +386 1 300 75 50 |
Ísland Vistor hf. Sími: +354 535 7000 | Slovenská republika Novartis Slovakia s.r.o. Tel: + 421 2 5542 5439 |
Italia Novartis Farma S.p.A. Tel: +39 02 96 54 1 | Suomi/Finland Novartis Finland Oy Puh/Tel: +358 (0)10 6133 200 |
Κύπρος Novartis Pharma Services Inc. Τηλ: +357 22 690 690 | Sverige Novartis Sverige AB Tel: +46 8 732 32 00 |
Latvija Novartis Pharma Services Inc. Tel: +371 67 887 070 |
Date of the last revision of this prospectus
Detailed information about this medication is available on the European Medicines Agency website: http://www.ema.europa.eu/.
- Country of registration
- Average pharmacy price7.65 EUR
- Active substance
- Prescription requiredYes
- Manufacturer
- This information is for reference only and does not constitute medical advice. Always consult a doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to AZOPT 10 mg/ml EYE DROPS IN SUSPENSIONDosage form: EYE DROP, 10 mg/mlActive substance: brinzolamideManufacturer: Laboratorio Stada S.L.Prescription requiredDosage form: EYE DROP, 20 mg/mlActive substance: dorzolamideManufacturer: Tiedra Farmaceutica S.L.Prescription requiredDosage form: EYE DROP, 10 mg/ml + 2 mg/mlActive substance: brinzolamide, combinationsManufacturer: Zentiva K.S.Prescription required
Online doctors for AZOPT 10 mg/ml EYE DROPS IN SUSPENSION
Discuss questions about AZOPT 10 mg/ml EYE DROPS IN SUSPENSION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.
Frequently Asked Questions
